• Sell Pharmaceutical Grade High Purity Peptides Lanreotide Powder for Cancer Treatment CAS:108736-35-2

Sell Pharmaceutical Grade High Purity Peptides Lanreotide Powder for Cancer Treatment CAS:108736-35-2

stars, based on ( 0 )reviews
$1.00 kilogram
0items available

Sell Pharmaceutical Grade High Purity Peptides Lanreotide Powder for Cancer Treatment CAS:108736-35-2



We are factory from China.We make peptides and HGH from China 


We can also make capsules, tablets, and liquid drops. Customers brand is accpetable.


Our email is sales@sarms4muscle.com



Sell Pharmaceutical
High Purity Peptides
Lanreotide Powder 
Cancer Treatment
CAS:108736-35-2





1.Basic info.

 

Product:Lanreotide

CAS No.:108736-35-2
Synonyms: LANREOTIDE;AUTOGEL;BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE;BIM-23014;ANGIOPEPTIN;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, (DISULFIDE BOND);IPSTYL
MF: C54H69N11O10S2
MW: 1096.32
CAS:108736-35-2
Assay:98%
Appearance:white to off-white lyophilised powder


2.Product Description:

 

Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. However, while somatostatin is quickly broken down in the body (within minutes), lanreotide has a much longer half-life, and produces far more prolonged effects.The efficacy of lanreotide has not been extensively studied, and results differ greatly between trials and formulations.

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.

Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.

 

3.Product Applications:

 

Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes.

Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.

Lanreotide ,In Dec 2014 the US FDA approved lanreotide for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Lanreotide-------Side effects

Lanreotide ,The main side effects of lanreotide treatment are mild to moderate pain at the injection site and gastrointestinal disturbances, such as diarrhea, nausea and vomiting. Isolated cases of gallstone formation have been associated with use of lanreotide, particularly over long periods of time.

 

4.Related products:

 

Product Name

CAS No.

Product Name

CAS No.

Sincalide

25126-32-3

Salcitonin

47931-85-1

Liraglutide

204656-20-2

Terlipressin

14636-12-5

Leuprorelin

74381-53-6

Histrelin

76712-82-8

Octreotide

79517-01-4

Ipamorelin

170851-70-4

Oxytocin

50-56-6

Melanotan II

121062-08-6

Teriparatide

52232-67-4

Sermorelin

86168-78-7

Alarelin

79561-22-1

Deslorelin

57773-65-6

Exenatide

141732-76-5

Bivalirudin

128270-60-0

Angiotensin

1407-47-2

CJC-1295

863288-34-0

Argipressin

113-79-1

GHRP-2

158861-67-7

Atosiban

90779-69-4

GHRP-6

87616-84-0

Cetrorelix

120287-85-6

Gonadorelin

33515-09-2

Desmopressin

16679-58-6

Met-Enkephaline

58569-55-4

Enfuvirtide

159519-65-0

PT141

189691-06-3

Eptifibatide

188627-80-7

Somatostatin

38916-34-6

Glucagon

16941-32-5

Tetracosactide

16960-16-0

GLP-1

106612-94-6

Thymopentin

69558-55-0

Lysipressin

50-57-7

 

62304-98-7

MGF-24

 

Triptorelin

57773-63-4

Nesiritide

114471-18-0

Vapreotide

103222-11-3

Pramlintide

196078-30-5

Lanreotide

108763-35-2

GLP-1(7-36)

107444-51-9

Ziconotide Acetate

107452-89-1

Recent Reviews
+